Helpline 800-723-9166
Donate
Advance Online
Advance Online

FDA Approves Skyrizi for Plaque Psoriasis

The latest interleukin-23 inhibitor is aimed at adults with moderate-to-severe psoriatic disease.

April 24, 2019
Recent Advance ArticlesNPF Logo
Psoriasis or Eczema?
NPF Logo
My Pregnancy with Psoriatic Disease
NPF Logo
A Champion for Change

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.